University of Nebraska Wins the Abbott and Big Ten Conference’s Nationwide ‘We Give Blood Drive’ Competition, Receives $1 Million Grant from Abbott

Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten nationwide competition this college football season, helping save as many as 60,000 lives Nebraska’s win was announced at the Discover Big Ten Football Championship Game where…

University of Nebraska Wins the Abbott and Big Ten Conference’s Nationwide ‘We Give Blood Drive’ Competition, Receives $1 Million Grant from Abbott

Nearly 20,000 Big Ten students, alumni and fans across the country donated blood as part of the Abbott-Big Ten nationwide competition this college football season, helping save as many as 60,000 lives Nebraska’s win was announced at the Discover Big Ten Football Championship Game where…

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Data presented at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH) NORTH CHICAGO, Ill., Dec. 7, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced updated results from the Phase 1b/2 EPCORE® NHL-2 trial evaluating fixed-duration investigational…

Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting

– 82% ORR (27 of 33 pts) and 48% CR/CRh (16 of 33 pts) in SAVE trial studying revumenib in combination with venetoclax and decitabine/cedazuridine in R/R AML – – 64% ORR (62 of 97 pts) and 23% CR/CRh (22 of 97 pts) with high rates of MRD negativity and ability to proceed to HSCT in…

New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients

ROTTERDAM, the Netherlands and SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, inflammatory, and infectious diseases, announce that groundbreaking data on the…

MosquitoMate receives first Vector Expedited Review Voucher (VERV) from the US Environmental Protection Agency

LEXINGTON, Ky., Dec. 7, 2024 /PRNewswire/ — The US Environmental Protection Agency (EPA) has just announced MosquitoMate as its first awardee in a new effort to fight the growing crisis of mosquito transmitted diseases. To help address the growing problem, in 2022 Congress mandated that…

TEDA célèbre 40 ans d’innovation, d’ouverture inclusive et de développement synergique

TIANJIN, Chine, 7 décembre 2024 /PRNewswire/ — La zone de développement économique et technologique de Tianjin (« TEDA »), créée en 1984 avec l’approbation du Conseil d’État chinois, célèbre son 40e anniversaire. Ce nouveau jalon célèbre la transformation d’une friche saline en une zone…

Les figurines de Blokees issues de plusieurs PI émerveillent les fans au Comic Con de Singapour 2024

SHANGHAI, 7 décembre 2024 /PRNewswire/ — Pendant les deux jours du Comic Con de Singapour 2024 (7-8 décembre), Blokees a dévoilé sa nouvelle collection Sesame Street pour la première fois au niveau mondial et a présenté un vaste éventail de figurines. La présentation de Blokees au SGCC…

Building Homes for Heroes Gifts 400th Home, Marking Historic Achievement in Veteran and First Responder Support

Building Homes for Heroes & Hillwood Properties partner to gift milestone home in Dallas, Texas NEW YORK, Dec. 7, 2024 /PRNewswire/ — Building Homes for Heroes today marked a transformative milestone with the gifting of its 400th home to U.S. Army Specialist Joshua Sager and his family…

ZETA Investors Have Opportunity to Lead Zeta Global Holdings Corp. Securities Fraud Lawsuit

NEW YORK, Dec. 7, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zeta Global Holdings Corp. (NYSE: ZETA) between February 27, 2024 and November 13, 2024, both dates inclusive (the “Class Period”), of the important January…